Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_2
1
17%
Ph phase_3
1
17%
Ph not_applicable
2
33%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(4)
Terminated(2)

Detailed Status

Completed4
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
80.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (25.0%)
Phase 31 (25.0%)
N/A2 (50.0%)

Trials by Status

withdrawn117%
completed467%
terminated117%

Recent Activity

0 active trials
Showing 5 of 6
completed

Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3

NCT00688246
completednot_applicable

Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast Cancer

NCT00892515
completedphase_3

Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial

NCT00354302
terminatedphase_2

Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone Metastases

NCT00634582
withdrawnnot_applicable

Omega-3 Fatty Acids in Treating Patients With Advanced Prostate Cancer

NCT00996749
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT00688246

Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3

Completed
NCT00892515Not Applicable

Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast Cancer

Completed
NCT00354302Phase 3

Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial

Completed
NCT00634582Phase 2

Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone Metastases

Terminated
NCT00996749Not Applicable

Omega-3 Fatty Acids in Treating Patients With Advanced Prostate Cancer

Withdrawn
NCT00458588

Long-Term Effect of Adolescent Diet on Hormones and Breast Cancer Risk in Women Previously Enrolled in the Dietary Intervention Study in Children

Completed

All 6 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
6